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Gene expressionCdk12 and Cdk13 are Cdc2-related proteins that share 92% identity in their kinase domains. Using in situ hybrid-
ization and Western blot analysis, we detected the expression of Cdk12 and Cdk13mRNAs and their proteins in
developing mouse embryos, especially during development of the nervous system. We explored the roles of
Cdk12 and Cdk13 in neuronal differentiation using the P19 neuronal differentiation model. Upon knockdown
of Cdk12 or Cdk13, no effect on differentiated cell numbers was detected, but a substantial decrease of numbers
of neurons with long neurites was identiﬁed. Similarly, knockdown of Cdk12 or Cdk13 in primarily cultured cor-
tical neurons shortens the averaged axonal length. A microarray analysis was used to examine changes in gene
expression after knockdown or overexpression of Cdk12 and we identiﬁed Cdk5 as a molecule potentially in-
volved inmediating the effect of Cdk12 and Cdk13. Depletion of Cdk12 or Cdk13 in P19 cells signiﬁcantly reduces
Cdk5 expression at both themRNA and protein levels. Expression of Cdk5 protein in the developingmouse brain
is also reduced in conditional Cdk12-knockout mice in proportion to the residual amount of Cdk12 protein pres-
ent. This suggests that the reduced axonal outgrowth after knockdown of Cdk12 or Cdk13might be due to lower
Cdk5 expression. Furthermore, overexpression of Cdk5 protein in P19 cells was able to partially rescue the
neurite outgrowth defect observed when Cdk12 or Cdk13 is depleted. Together, these ﬁndings suggest that
Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5
expression.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Neurons are highly polarized cells with two functionally distinct do-
mains that emerge from the cell body; these are the single long axon,
which transmits signals, and themultiple shorter dendrites, which spe-
cialize in receiving signals (Craig and Banker, 1994). Once axon speciﬁ-
cation occurs, the axonal process begins to grow at a rate approximately
10 times faster than that of the dendritic processes (Dotti et al., 1988);
this is due to differences in the patterns of microtubule organization be-
tween the dendrites and the axons (Conde and Caceres, 2009; Kuijpers2, cyclin-dependent kinase 12;
system; DIV, days in vitro; K-S
rotubule-associated protein 2;
ament.
nces and Institute of Genome
an, ROC. Fax:+86 2 2823 4898.
. This is an open access article underandHoogenraad, 2011; Stiess and Bradke, 2011). Axonshave tau-bound
microtubules of uniform orientation with their plus end pointing out-
ward, whereas dendrites have microtubule-associated protein 2
(MAP2)-bound microtubules of mixed orientation with many minus
ends pointing outward (Baas et al., 1989; Burton, 1988; Conde and
Caceres, 2009). Axonal and dendritic microtubule networks further-
more differ in their patterns of post-translational modiﬁcations and
these result in unique interactions with other microtubule-associated
proteins (Hammond et al., 2010;Witte et al., 2008). Several types ofmi-
crotubule post-translational modiﬁcations, including tyrosination/
detyrosination and phosphorylation, are also known to modulate the
sorting mechanisms of motor proteins in axons and dendrites and
these consequently augment differences between axons and dendrites
(Fukushima et al., 2009; Sirajuddin et al., 2014). For example,
detyrosination modiﬁcation of microtubules occurs more frequently in
axons, which facilitates the recruitment of kinesin-1 to transport
collapsin response mediator protein-2 in axons (Hammond et al.,
2010; Kimura et al., 2005). The physiological relevance of microtubule
phosphorylation in axons and dendrites is another ﬁeld of activethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
11H.-R. Chen et al. / Experimental Neurology 261 (2014) 10–21research. It has been suggested that phosphorylation of themicrotubule
networks is able to positively or negatively regulate the polymeriza-
tion of microtubules (Fourest-Lieuvin et al., 2006; Khawaja et al.,
1988). For example, Cdk1/cyclin B-mediated phosphorylation at
Ser172 of β-tubulin impairs the incorporation of these modiﬁed
subunits into polymers (Fourest-Lieuvin et al., 2006). Similarly,
phosphorylation of β-tubulin at tyrosine residues prevents the in-
corporation of these β-tubulin molecules into microtubules (Ley
et al., 1994).
One of themolecules engaging in neuronal microtubule dynamics is
Cdk5, a member of cyclin-dependent kinases (Cdk) (Smith, 2003;
Veeranna et al., 2000). Cdk5 phosphorylates a number of neuronal cyto-
skeletal proteins involved in neuronal migration, neurite growth and
synaptogenesis (Cheung and Ip, 2007; Cheung et al., 2006; Cruz and
Tsai, 2004; Xie et al., 2006). Furthermore, substrates of Cdk5, such as
tau, MAP2, the dynein-associated protein, Nudel, and SIRT2, are
known to be involved in cytoskeletal dynamics. This implies that Cdk5
plays a role as a critical signal transmission hub that is positioned be-
tween a range of cell surface receptors and various cytoskeletal systems
(Pandithage et al., 2008; Smith, 2003; Speranza et al., 2013; Veeranna
et al., 2000).
Protein kinases are critical regulators that affect the cell cycle, dif-
ferentiation, metabolism, cell death and various other critical cellular
processes (Ickowicz et al., 2012; Malumbres, 2011; Yuan et al., 2013)Fig. 1. Expression of Cdk12 and Cdk13 in the developing nervous system. (A) Cdk12 and Cdk1
whole-mount in situ hybridization. The results from the antisense probes are shown in a–d and
in all cells, except in the heart (H), but with higher levels in forebrain (F), midbrain (M), primiti
Cdk13mRNA expression (e–h). The scale bar represents 300 μm. (B, C) Expression of the Cdk1and we previously explored the roles of a number of uncharacterized
protein kinases. In this study we have focused on Cdk12 and Cdk13
due to their abundant expression in the nervous system (Lin and
Fann, 1998). They share 92% identity in the kinase domain, and are
known to interact with cyclin L and cyclin K (Blazek et al., 2011;
Bosken et al., 2014; Chen et al., 2006, 2007; Dai et al., 2012). At the
molecular level, they are able to facilitate transcription of long
genes with many exons, and are involved in mRNA alternative splic-
ing (Blazek et al., 2011; Chen et al., 2006, 2007; Rodrigues et al.,
2012). At the cellular level, Cdk12 and Cdk13 are able to maintain
self-renewal in embryonic stem cells (Dai et al., 2012). In the present
study, we examined additional possible functions of Cdk12 and
Cdk13 during neuronal development. Using P19 cells as a neuronal
differentiation model, we asked whether changes in Cdk12 and
Cdk13 expression affect neuronal differentiation and neurite out-
growth. The P19 cells are mouse embryonic carcinoma cells and are
able to differentiate into neurons when there is overexpression of
the proneural gene Ascl1 (Farah et al., 2000). We found that reduced
expression of Cdk12 or Cdk13 resulted in a shortening of neurite
elongation in P19 cells and an inhibition of axonal extension in
primary cultured cortical neurons, but reduced Cdk12 or Cdk13
expression had no effects on dendrite extension. We further demon-
strated that Cdk12 and Cdk13 promote axonal elongation through a
common signaling pathway that involves modulation of Cdk53mRNA expression in mouse embryos at various developmental stages was analyzed by
e–h, while those from the sense probes are shown in a′–d′ and e′–h′. Cdk12 is expressed
ve streak (PS) and tail budmesoderm (TBM). A similar expression patterns is observed for
2 and Cdk13 proteins in developing brains was analyzed byWestern blotting.
12 H.-R. Chen et al. / Experimental Neurology 261 (2014) 10–21expression at the RNA level. This is a novel ﬁnding that couples
Cdk12 and Cdk13 functioning with Cdk5 signaling during axonal
elongation.
Materials and methods
Animals
Adult C57BL/6J mice were obtained from the National Laboratory
Animal Center (Taipei, Taiwan). All mice were handled according to
the university guidelines and all experiments were approved by the
National Yang-Ming University Animal Care and Use Committee. For
the timed pregnancies, mice were set up in the late afternoon and
when plugs were detected the next morning, this was designated
as E0.5.
Whole-mount in situ hybridization
Mouse embryos were dissected at different developmental stages,
ﬁxed in 4% paraformaldehyde, and permeabilized by treatment with
proteinase K. After hybridization andwashing, embryoswere incubated
with an alkaline phosphatase-conjugated anti-digoxygenin antibody
(Roche), washed again and then stained using a NBT/BCIP mixture
(Roche) in the presence of 10% polyvinyl alcohol (31–50 kD; Sigma).
After visualization of the alkaline phosphatase activity, embryos were
post-ﬁxed and cleared in 100% glycerol for photography. Sense and an-
tisense RNA probes were synthesized using an in vitro transcription kit
from Roche, and were puriﬁed using a Sephadex G-50 column
(Amersham Biosciences). RNA inhibitor (RNase) was purchased from
Promega.
Vector construction
The various Cdk12 and Cdk13 plasmids had been constructed pre-
viously (Chen et al., 2006, 2007). Protocols described by Chung et al.
(2006) were followed to construct the microRNA mimics. Oligonu-
cleotides against mouse Cdk5, Cdk12 and Cdk13 sequences as well
as against their equivalent scramble sequences were synthesized
and cloned into the vector UI4-puro-SIBR to obtain pCdk5-s,
pCdk5-i1, pCdk5-i2, pCdk12-s, pCdk12-i1, pCdk12-i2, pCdk13-s,
pCdk13-i1 and pCdk13-i2, or into the vector UI4-GFP-SIBR to obtain
pCdk12-s-e, pCdk12-i1-e, pCdk13-s-e and pCdk13-i1-e. The se-
quences of the oligonucleotides are listed in Table S1. Mouse Cdk5
activator, p35, was ampliﬁed by PCR and cloned into the vectors
pUS2. All constructs were veriﬁed by restriction enzyme mapping
and sequencing.
Antibodies
Rabbit anti-Cdk12 and mouse anti-Cdk13 polyclonal antibodies had
been produced previously (Chen et al., 2006, 2007). Mouse anti-β-Fig. 2. Knockdown of Cdk12 and Cdk13 decreases neurite elongation in P19 cells. (A) A sche
transfectedwith the indicatedCdk12 constructs. (C) Differentiation rates of P19 cells transfected
The number of TuJ1-positive cells was divided by the number of DAPI positive cells in 30 rando
constructs. The lengths of neurites marked by TuJ1 staining were manually quantiﬁed for each
selected ﬁelds for each transfected condition were evaluated. Data from three independent exp
***, p b 0.001. (E) The distribution of neurite lengths using P19 cells transfected with the indica
Statistical analysis using two sampleKolmogorov–Smirnov test (K–S test) shows p N 0.05 for pC
and pCdk12-i2, respectively, when compared to pUI4. (F) Representative images of P19 cell
transfected with the indicated constructs. (H) Average neurite length of P19 cells transfected w
mean± SEM. ***, p b 0.001 by Student's t-test. (I) Distribution of neurite lengths of P19 cells tra
sented as mean ± SEM. The two sample K–S test shows p N 0.05 for pCdk13 when compared t
spectively, when compared to pUI4. Scale bars 100 μm.tubulin antibody (E7, 1:10000) and anti-Myc antibody (9E10, 1:5000)
were obtained from the Developmental Studies Hybridoma Bank.
Mouse anti-Flag M2 monoclonal antibody (1:1000) was purchased
from Sigma. Mouse anti-Cdk5, rabbit anti-MAP2 and mouse anti-tau1
antibodies were obtained from Millipore. Mouse anti-pan-axonal neu-
roﬁlament marker (SMI312) and mouse anti-neuronal class III β-
tubulin (TuJ1) were purchased from Covance. TRITC-conjugated goat
anti-mouse antiserum was obtained from the Jackson Laboratory.
Other secondary antisera were purchased from Chemicon or Bethyl
Laboratories.
Cell culture and transfection
P19 cells were cultured in α-minimal essential medium (α-MEM)
with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml
streptomycin, and 2 mM glutamine and incubated in a 5% CO2/95% hu-
midiﬁed atmosphere at 37 °C. For neuronal differentiation, P19 cells
were transfected with pAscl1 and other plasmids using Lipofectamine
2000 (Invitrogen) according to the instructions of the manufacturer.
The expression plasmid pAscl1 (pUS2-Ascl1) from D. L. Turner was
used for neuronal differentiation, which has previously been shown to
convert P19 cells into a relatively homogenous population of electro-
physiologically differentiated neurons (Farah et al., 2000; Yu et al.,
2002). Eight hours after transfection, 8 μg/ml puromycin was applied
to select transfected cell. The cells were then replated onto 6-well plates
coated with 2 μg/ml laminin (Invitrogen) at 24 h after transfection, and
cultured in 1% FBS OPTI-MEM. The medium was changed at two days
after transfection. Cells were harvested for immunocytochemistry or
protein extraction at three days after transfection. Mouse cortical neu-
rons were prepared from E14.5 mouse embryos. The cortex was me-
chanically dissociated by passing through a glass pipette for twenty
times and then ﬁltered through a 70-μm nylon mesh ﬁlter (BD Biosci-
ences). Cells were plated onto plastic culture plates coated with
30 μg/ml poly-L-lysine and 2 μg/ml laminin and cultured in Dulbecco's
modiﬁed Eagle's medium containing 10% FBS, 100 U/ml penicillin and
streptomycin, and N2 supplement and B27 supplement (Invitrogen).
The cells were kept at 37 °C in a humidiﬁed atmosphere of 5% CO2
and 95% air. To deliver plasmids into cortical neurons, electroporation
was performed before plating using the Amaxa Mouse Neuron
Nucleofector kit and the Amaxa Nucleofecor II (Lonza). Conditions
were optimized for 4 × 107 cells and 10 μg of plasmid per electropora-
tion, which gave a survival and transfection efﬁciency of 60% and 35%
to 40%, respectively.
Immunoﬂuorescence microscopy and neurite counting
Cultured neuronswere rinsed oncewith PBS and ﬁxed in 4%parafor-
maldehyde for 1 h. Samples were stained with the appropriate primary
and secondary antibodies and then ﬁnally stained with DAPI (1 μg/ml)
for 15 min. Samples were then examined using a ﬂuorescence micro-
scope (Zeiss). Numbers of TuJ1-positive cells and DAPI-positive cellsmatic depiction of the experimental procedure. (B) Representative images of P19 cells
with the indicated constructs. Differentiated neuronal cellswere detectedbyTuJ1 staining.
mly selected ﬁelds. (D) Average neurite length of P19 cells transfected with the indicated
selected neuron using Neuron J software. In each experiment, 300 neurons from randomly
eriments were analyzed by Student's t-test and are presented asmean± SEM. **, p b 0.01;
ted constructs. Data from three independent experiments are presented as mean ± SEM.
dk12when compared to pEF, and p N 0.05, p b 0.01, and p b 0.001 for pCdk12-s, pCdk12-i1,
s transfected with the indicated Cdk13 constructs. (G) Differentiation rates of P19 cells
ith the indicated constructs. Data from three independent experiments are presented as
nsfectedwith the indicated constructs. Data from three independent experiments are pre-
o pEF, and p N 0.05, p b 0.001, and p b 0.001 for pCdk13-s, pCdk13-i1, and pCdk13-i2, re-
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The differentiation rate was calculated by dividing TuJ1-positive cell
numbers by DAPI-positive cell numbers. The tracking of P19 cellneurites and cortical neurons neurites was performed manually, and
the length of each neurite was quantiﬁed using the Image J plugin,
ImageJ. In each experiment, 300 neurons from randomly selected ﬁelds
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least three times.
Targeted disruption of the mouse Cdk12 gene
To generate Cdk12 conditional knockout mice, a targeting vector
containing Cdk12 sequences between exon 3 and exon 4 ﬂanked by
loxP, and FRT-ﬂanked Neo cassette was prepared from a BAC clone
using the recombineering approach (Copeland et al., 2001; Liu
et al., 2003). The targeting vector was linearized and electroporated
into embryonic stem (ES) cells, which was performed by Transgenic
Mouse Models Core Facility, Taiwan. After selection with antibiotics,
cell clones with correct homologous recombination were identiﬁed
by Southern blot hybridization. After Neo pop-out, a correctly
targeted ES clone was injected into blastocysts and the resultant chi-
meras were bred with C57BL/6J mice. Genotyping was performed by
Southern blotting and/or PCR using the probe and primers listed in
Table S1. To conditionally delete Cdk12 in the nervous system,
NestinCreERT2 mice were used for Cre-mediated recombination
after injecting Tamoxifen. Most mice used for this study were on a
C57BL/6-129Sv mixed background.
Protein extraction and Western blotting
Previously described procedures were followed during these exper-
iments (Wong et al., 2010).
Quantitative real-time PCR assay
Total RNAwas extracted using a RNeasy Mini kit (Qiagen) follow-
ing the manufacturer's suggestions. Reverse transcription was per-
formed with 1.5 μg of total RNA using SuperScript III reverse
transcriptase (Invitrogen). The real-time quantitative PCR was per-
formed on a LightCycler 480 using the Universal Probe Library
(UPL) (Roche). A web service (http://qpcr.probeﬁnder.com/roche3.
html) was used to select targeted input sequences, UPL probes, and
primer pairs. The sequences of the primers are listed in Table S1.
Negative controls containing no cDNA template were included in
each experiment. The results were analyzed by LightCycler software
version 3.5 (Roche) to determine the threshold cycle (Cp) for each
reaction.
Results
Expression of Cdk12 and Cdk13 in the developing nervous system
Weusedwhole-mount in situ hybridization andWestern blotting to
detect the spatial and temporal expression patterns of Cdk12 and
Cdk13 at both the mRNA and protein levels. Cdk12 mRNA is present
in E6.5 embryo proper and trophoblasts (Fig. 1Aa). During E7–E7.5,
Cdk12 is expressed in all cells, but with stronger expression in the
primitive streak (PS) (Fig. 1Ab). In E8.5 and E9.5 embryos, stronger
signals are detected in the forebrain, midbrain and tail bud meso-
derm (TBM), but not in the heart (Figs. 1Ac and Ad). Cdk13 is also
ubiquitously expressed but not in the heart at the various devel-
opmental stages examined (Figs. 1Ae–Ah). We further analyzedFig. 3. Cdk12 and Cdk13 regulate neurite elongation through a common signaling pathway in d
P19 cells transfected with the indicated constructed. Ectopically expressed Cdk12 and Cdk13 w
with the indicated constructs are shown. (E, F) The average neurite lengths and the neurite le
are shown. *, p b 0.05. There is a signiﬁcant difference between the pCdk12-i1 and pCdk12-i1+
and neurite length distribution in P19 cells transfected with the indicated Cdk12 and Cdk13 c
pCdk13-i1 + pCdk12 groups by the two sample K–S test (p b 0.001). Scale bars 100 μm.expression of Cdk12 and Cdk13 at the protein level in the develop-
ing brain at later developmental stages and found that Cdk12 and
Cdk13 proteins were consistently expressed in the brain at all em-
bryonic stages (Figs. 1B and C), which suggests that Cdk12 and
Cdk13 may play a general role in the development of the nervous
system.
Knockdown of Cdk12 or Cdk13 leads to an axonal extension defect through
a common signaling pathway
Initially, we examined whether Cdk12 and Cdk13 participate in
neuronal differentiation using the P19 neuronal differentiation
model. P19 is a mouse embryonal carcinoma cell line that is able
to be induced to differentiate into neuronal cells by ectopic expres-
sion of proneural gene Ascl1 and gives rise to unipolar or bipolar
neurites. Overexpression constructs that increase Cdk12 or Cdk13
protein expression more than nine folds in P19 cells, and two RNA
interference constructs for each gene that decrease Cdk12 or
Cdk13 protein expression to less than 40% of the control level
were constructed (Figs. S1A and C). The Cdk12 interference
constructs do not inhibit Cdk13 protein expression, and vice versa
(Figs. S1B and D). Differentiated P19 cells exhibit unipolar or bipolar
neurites whose lengths can be revealed by staining with TuJ1
antibody, which recognizes a neuronal speciﬁc beta-III-tubulin
expressed in early postmitotic neurons. Overexpression of either
Cdk12 or Cdk13 in P19 cells was found not to affect differentiation
of P19 cells cultured for 3 days after transfection, either in terms of
the numbers of differentiated TuJ1-positive cells or in terms of the
average length of outgrown neurites (Figs. 2Bb, C, D, Fb, G, and H).
Surprisingly, however, knockdown of Cdk12 or Cdk13 decreased
the average lengths of neurites in differentiated P19 neurons
(312.66 ± 0.34 μm, mean ± SEM, for the pUI4 control, 227.17 ±
7.27 μm for pCdk12-i1, Fig. 2D; and 306.95± 4.3 μm for pUI4 control,
202.52 ± 5.75 μm for pCdk13-i1, Fig. 2H), although there was no
change in the numbers of differentiated cells (Figs. 2C and G). De-
tailed analysis of the neurite length distribution revealed that cells
with a deﬁciency in either Cdk12 or Cdk13 were able to send out pro-
cesses but had reduced capability to extend these processes to long
distances (N300 μm) (Figs. 2E and I). Thus, distribution of the neurite
length was skewed to the right in Cdk12-depleted and Cdk13-
depleted cells, suggesting that Cdk12 and Cdk13 are critical for
neurite elongation in P19 cells.
Next, we analyzed whether Cdk12 and Cdk13 affect axonal elon-
gation through a common pathway. Interestingly, overexpression of
Cdk13 in Cdk12-depleted cells reduced the percentage of short
neurite (100–200 μm) from 38% to 27%, and increased the percent-
age of longer neurite (300–400 μm) from 16% to 23% (Figs. 3B and
F). Overexpression of Cdk12 in Cdk13-depleted cells was also able
to decrease the percentage of short neurite (100–200 μm) from
44% to 33%, and to raise percentage of the longer neurite (300–
400 μm) from 8% to 13% (Figs. 3D and H). Furthermore, the average
neurite lengths after overexpression approached those of the control
cells, when compared to those of the Cdk12-depleted or Cdk13-
depleted P19 cells (Figs. 3E and G). These results suggest that the
same underlying signal pathway, at least in part, may mediate action
of both Cdk12 and Cdk13 (Fig. 3).ifferentiated P19 cells. (A, C) The expression levels of Cdk12, Cdk13, and Cdk5 proteins in
ere detected by anti-myc antibody. (B, D) Representative images of P19 cells transfected
ngth distribution of P19 cells transfected with the indicated Cdk13 and Cdk12 constructs
pCdk13 groups by the two sample K–S test (p b 0.01). (G, H) The average neurite lengths
onstructs are shown. *, p b 0.05. There is a signiﬁcant difference between pCdk13-i1 and
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neurons (Fig. S2), we examined whether Cdk12 and Cdk13 are
able to modulate neurite extension in cultured cortical neurons.
Dissociated cortical neurons derived from mouse E14.5 embryos
were electroporated with the various constructs. We used anti-
MAP2 antibody to demarkate dendrites, and anti-phosphorylated
neuroﬁlament antibody (SMI312) and anti-tau1 antibody to iden-
tify axons. After 3 days of culture in vitro (DIV), depletion of either
Cdk12 or Cdk13 did not affect the neuronal polarity in cultured cor-
tical neurons (Fig. S3). These neurons exhibited several MAP2-
positive processes, and one long SMI312-positive process. In
Cdk12-depleted and Cdk13-depleted cortical neurons, the average
length of dendrites was not affected (12.67 ± 1.19 μm in control
cells vs. 12.33 ± 1.44 μm and 12.36 ± 0.72 μm in Cdk12-depleted
and Cdk13-depleted neurons, respectively, Figs. 4A, B); however,
the average length of axons was decreased (101± 5.25 μm in control
cells vs. 42 ± 3.3 μm and 41 ± 2.05 μm in Cdk12-depleted and
Cdk13-depleted neurons, respectively, Figs. 4C, D). At 5 DIV, den-
drites and axons of the control neurons had grown further
(Figs. 4E–H). Dendrite growth had taken place in the Cdk12-
depleted and Cdk13-depleted neurons (compare Figs. 4F with B);
however, the growth of the axons of Cdk12-depleted and Cdk13-
depleted neurons was arrested during these two days (compare
Figs. 4H with D). Staining with tau1 gave similar results at 3 DIV
(Fig. S4). Together, these ﬁndings support the idea that Cdk12 and
Cdk13 are essential for axonal extension.
Expression of Cdk5 is regulated by Cdk12 and Cdk13
To dissect the underlying mechanisms by which Cdk12 and
Cdk13 regulate axonal elongation, we performed microarray analy-
sis and compared the global gene expression proﬁles of the control,
Cdk12-overexpressing and Cdk12-knockdown P19 cells. Using
these ﬁndings, we then selected candidate genes whose expression
was decreased in the Cdk12-knockdown P19 cells but did not change
in the Cdk12-overexpressing P19 cells, both in comparison to cells
transfected with the control vector. Among these candidates identi-
ﬁed, Cdk5 mRNA was found to be down-regulated in Cdk12-
knockdown P19 cells to 27% of the control using the microarray anal-
ysis. As Cdk5 is an important molecule in terms of neurite outgrowth
during neural development, we then investigated whether Cdk12
and Cdk13 were indeed able to regulate Cdk5 mRNA expression
using quantitative RT-PCR analysis. Knockdown of either Cdk12 or
Cdk13 was found to reduce Cdk5 mRNA level to ~40% of the control
level (Fig. 5A), which is a level compatible with the decreased levels
of Cdk12 or Cdk13 protein when their corresponding RNA interfer-
ence constructs are transfected into P19 cells. Cdk5 protein expres-
sion is also reduced to ~50% of the control (Fig. 5B, C), which
suggests that regulation of Cdk5 by Cdk12 and Cdk13 is primarily
at the RNA level.
Previously we have generated a Cdk12 conditional knockout
mouse by inserting loxP sites into intron 2 and intron 4 (Fig. S5A).
We took advantage of variable efﬁciency of the Cre recombinase in
embryos after injecting Tamoxifen into pregnant mice, and asked
whether there is a dose–response relationship between the in vivo
expression of Cdk12 and the expression of Cdk5. We crossed
Cdk12f/f mice with Nestin-CreERT2; Cdk12del/+mice, and injectedFig. 4.Cdk12 and Cdk13 enhance axonal elongation in primary cultured cortical neurons. Cortica
cells were cultured, ﬁxed, and immunostained with anti-MAP2 (A, E) or anti-SMI312 (C, G) an
positive neurites. (B, D, F, H) Quantiﬁcation of the length ofMAP2-positive dendrites and the SM
were collected from300 randomly selected cells. Data from three independent experimentswer
Scale bars 50 μm.Tamoxifen at E10.5 into pregnant mice. Whole brain was then dis-
sected from the E14.5 embryos and protein extracts from different
embryos were subjected to Western analysis using anti-Cdk12 anti-
bodies and anti-Cdk5 antibodies (Fig. 5D). A linear correlation be-
tween Cdk12 expression and Cdk5 expression with a value for r of
0.98 was found (Fig. 5E).
Overexpression of Cdk5 partially rescues effects of Cdk12 or Cdk13
knockdown
To examine whether Cdk5 is the downstream gene that is con-
trolled by Cdk12 and Cdk13 in P19 cells, we performed RNA inter-
ference experiments to knockdown Cdk5 mRNA and analyzed the
effect on neurite extension in P19 cell model. Transfection of two
RNA interference constructs (pCdk5-i1 and pCdk5-i2) was found
to reduce Cdk5 protein expression to 50% of the control (Fig. S1E).
Upon knockdown of Cdk5, the number of differentiated P19 cells
does not change (Fig. 5G), but it was found that the neurite length
distribution was skewed to the right in a pattern that is similar to
what we observed for Cdk12-depleted or Cdk13-depleted cells
(Figs. 5H, I). It should be noted that the decrease in average neurite
length and change in skewness after knockdown of Cdk5 were
found to be less than the changes induced by Cdk12 and Cdk13
depletion.
We next examine whether overexpression of Cdk5 was able to res-
cue the defects found in Cdk12-depleted and Cdk13-depleted P19
cells. When Cdk5 was ectopically expressed in Cdk12-depleted and
Cdk13-depleted P19 cells with Cdk5 activator, p35, the neurites grew
to a longer length; furthermore, the average neurite length and the dis-
tribution of the neurite length approached that of the control cells,
when compared to the Cdk12-depleted or Cdk13-depleted P19 cells
(Fig. 6). Thus, the defect of neurite extension due to knockdown of
Cdk12 or Cdk13 was found to be partially rescued by Cdk5 overexpres-
sion. However, overexpression of Cdk12 or Cdk13 in Cdk5-depleted P19
cells had no effect on neurite outgrowth in comparison to knockdown of
Cdk5 alone (Fig. S6). These ﬁndings suggest that the Cdk5 is one of the
downstream mediators for Cdk12 and Cdk13 when axonal elongation
occurs.
Discussion
Cdk12 and Cdk13 are essential for axonal elongation
Our investigation provides evidence that Cdk12 and Cdk13 contrib-
ute to axonal growth. Upon depletion of Cdk12 or Cdk13, cultured P19
cells and primary cortical neurons lose the ability to extend their
axons to greater distances, although they are still able to initiate
neurites (Figs. 2 and 4). Overexpression of Cdk13 is able to partially res-
cue the neurite outgrowth defect in Cdk12-depleted P19 cells, and vice
versa, which suggests that they act through common downstream
effector(s) to promote axonal elongation (Fig. 3). One protein affected
by both Cdk12 and Cdk13 is Cdk5, and both are able to modulate Cdk5
protein expression in vitro; furthermore, overexpression of Cdk5 in
Cdk12-depleted and Cdk13-depleted P19 cells is able to partially rescue
the neurite outgrowth defect (Fig. 6). Interestingly, overexpression of
Cdk13 increases the endogenous Cdk5 protein expression level and is
able to rescue partially the defects in Cdk12-depleted P19 cells, alsol neurons from the E14.5mouse cortexwere transfectedwith the indicated constructs. The
tibodies at 3 DIV (A–D) and 5 DIV (E–H). The arrows indicate MAP2-positive and SMI312-
I312-positive axons as shown in A, C, E, and Gwas performed. For each condition, the data
e analyzed by Student's t-test and are presented asmean±SEM. **, p b 0.01; ***, p b 0.001.
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depleted P19 cells gives the same results (Figs. 3A, C). The ﬁndings
from Cdk12 knockout mice further conﬁrm that expression of Cdk5 is
indeed regulated by the level of Cdk12 proteins in vivo. However, the
observation that Cdk5 overexpression in Cdk12-depleted and Cdk13-
depleted P19 cells brings about only a partial rescue of the neurite
elongation defect, which implies that there are other effectors in-
volved in Cdk12-dependent and Cdk13-dependent axonal elonga-
tion (Fig. 7).
Cdk12 and Cdk13 have overlapping, but not identical, functions
Cdk12 and Cdk13 have similar protein sequences and structural
motifs. They are known to be engaged in a number of similar biolog-
ical processes (Chen et al., 2006, 2007; Dai et al., 2012; Kohoutek and
Blazek, 2012). For example, both Cdk12 and Cdk13 play an indis-
pensable role in maintaining the pluripotency of mouse embryonic
stem cells (Dai et al., 2012). Furthermore, both Cdk12 and Cdk13
take part in RNA splicing regulation in a similar manner (Chen
et al., 2006, 2007). In this study, we have shown that their expression
patterns seem also to be very similar (Fig. 1). Expression of Cdk12
and Cdk13 is initiated quite early during development, beginning
as early as the E6.5 mouse embryo. Both are expressed ubiquitously,
except that they are both absent from the developing heart. This sim-
ilarity in expression pattern and function between Cdk12 and Cdk13
suggests that deﬁciency in either protein is unlikely to generate an
obvious phenotype in mouse embryos. It is thus surprising that
Cdk12 knockout mice die at post-implantation stage at E5.5 (data
not shown) and this suggests that Cdk13 is not a redundant version
of Cdk12 and is not able to completely complement Cdk12 deﬁciency.
Furthermore, it has been shown that Cdk12, rather than Cdk13, acti-
vates transcription via the phosphorylation of Ser2 at the carboxyl-
terminal domain of RNAPII and this then facilitates transcription of
long exons during elongation (Bartkowiak et al., 2010; Blazek et al.,
2011; Cheng et al., 2012; Ghamari et al., 2013). It is likely that
these two genes are derived from an ancestor gene but have then
evolved divergently and are now an evolutionary distinct far part
in vertebrates (Malumbres et al., 2009). This may have resulted in
subtle differences in terms of cellular localization as well as changes
in their preference in terms of substrates and cyclins. A more thor-
ough study is needed in the future in order to explore these fascinat-
ing possibilities.
Axons, but not dendrites, are affected by the activity of Cdk12 and Cdk13
Axonal outgrowth involves many steps. The roles of Cdk12 and
Cdk13 seem to be limited to axonal elongation. They are not required
for speciﬁcation and maintenance of neuronal polarity, since knock-
down of Cdk12 and Cdk13 does not affect the numbers of SMI312-
positive cortical neurons or MAP2-positive cortical neurons at 3
DIV and 5 DIV (Figs. 4 and S4). However, knockdown of Cdk12 and
Cdk13 dose affect axonal elongation and this effect occurs without
affecting dendrite extension. This suggests that both Cdk12 andFig. 5. Depletion of Cdk12 or Cdk13 leads to down-regulation of Cdk5 and depletion of Cdk5
measure Cdk5 expression in P19 cells transfected with various Cdk12 or Cdk13 constructs. D
sented as mean ± SEM. **, p b 0.01. (B) Knockdown of Cdk12 or Cdk13 in P19 cells reduces
data from three independent experiments were analyzed by Student's t-test and are presen
protein expression in embryonic brains with different Cdk12 knockout backgrounds. (E) Th
present using mouse embryos that had different genotypes and different levels of Cre activiti
with *) were deﬁned as having an arbitrary unit (A.U.) value of one. (F) Representative image
P19 cells transfected with the indicated constructs. (H) The average neurite lengths of P19 ce
are presented as mean ± SEM. **, p b 0.01; ***, p b 0.001 by Student's t-test. (I) The distribu
three independent experiments are presented as mean ± SEM. The two sample K–S test sh
when compared to pUI4. Scale bars 100 μm.Cdk13 are able to regulate the axonal speciﬁc microtubule organiza-
tion but not dendritic cytoskeletal organization, although expression
of Cdk12 and Cdk13 is distributed evenly across both dendrites and
axons (data not shown). Currently, the underlying mechanisms by
which Cdk12 and Cdk13 are able to generate this differential effect
remain unclear. It seems likely that Cdk12 and Cdk13 regulate tubu-
lin polymerization and microtubule stability, which is highly critical
in axons. Silencing of Cdk12 and/or Cdk13 may also bring abnormal
microtubule remodeling and a change in microtubule dynamics in
axons. Details of the downstream Cdk12 and Cdk13 substrate pro-
teins and how they contribute to this differential effect on axons
and dendrites remain obscure. Future investigation in this area will
further strengthen our understanding of the development of axons
and dendrites.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.expneurol.2014.06.024.
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